Oei, Arlene L <br/><br/>
Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.  [electronic resource] 

 -  Oncotarget  Apr 2017 
 - 28116-28124 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.15922  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>DNA Damage--drug effects<br/>Female<br/>Fever--therapy<br/>Genes, BRCA1<br/>Genes, BRCA2<br/>Homologous Recombination<br/>Humans<br/>Neoplasms--genetics<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Rats<br/>Synthetic Lethal Mutations--drug effects